Marseille, June 2026 – After two years of R&D supported by the France 2030 investment programme – Artificial Intelligence – Medical Imaging – Région Sud, the Marseille-based startup Ventio has reached a major milestone in its development with the filing …
Ventio has been invited to present its findings to clinicians and researchers working on rare diseases Neurodegenerescence with Brain Iron Accumulation (NBIA). You can find the announcement for this symposium and the program here! Friday, june 5th 8h45 – 9h15 …
Following last week’s “Favorite” award at TDH2026, the momentum continues at Ventio! 🙏 We are thrilled to have won the Disruptive Innovation Award at the CIC Start Innovation Awards! 🎉 Thank you to the jury for their support! We accept …
We are honoured and proud to have been awarded the „Jury’s choice“ prize last Thursday at the Hypergrowth Awards. 🙏 This recognition means a great deal to us and serves as a tribute to the hard work, dedication and vision of …
Our mission: to better understand, diagnose earlier, and accurately monitor neurodegenerative diseases by tracking brain iron. To achieve this mission, we have taken three major steps: ✅ A partnership to strengthen understanding of these diseasesLaunch of the QSM for Alzheimer’s Disease …
Whether for profit, espionage or destabilization, attackers‘ growing mastery of cloud environments is leading to an increase in attack attempts. Whether an organization wants to migrate to the cloud, or is already using it, it needs to be aware of …
Samira joins the Ventio team as a research scientist! Samira, You joined the Ventio team a few weeks ago as a research scientist. Welcome! Can you introduce yourself in a few words and tell us more about your academic and …
Quantitative Susceptibility Mapping of the Cervical Spinal Cord at 3T and Application to Multiple Sclerosis NMR in Biomedicine, 2026, 39 (6) Benjamin Streichenberger (1) , Mathieu Santin (2) , Ludovic de Rochefort (3) , Quentin Duché (4) , Catherine Guillemot (5), Samira Mchinda (3) , Stéphane Roche (3) , Anne Kerbrat (1, 6) , Elise Bannier (1, …
Feasibility and Potential of Quantitative Susceptibility Mapping in Neurodegeneration with Brain Iron Accumulation (NBIA) at Clinical Magnetic Field European Society for Magnetic Resonance in Medicine and Biology, 41st annual scientific meeting; MR to the limits and beyond, Oct 2025, Marseille, …
Iron load in the normal aging brain measured with QSM and R2* at 7T: findings of the SENIOR cohort Miguel Guevara, Stéphane Roche, Vincent Brochard, Davy Cam , Jacques Badagbon , Yann Leprince, Michel Bottlaender, Yann Cointepas, Jean-François Mangin, Ludovic de Rochefort , Alexandre Vignaud Frontiers in Neuroimaging, Sec. Neuroimaging …
Reusing health data to develop value-added tools for radiology Stéphane Roche, Miguel Guevara, Ludovic de Rochefort , Alexandre Vignaud Journées Francophones de Radiologie, 4-7 octobre, Paris, France Abstract : Objectif Health data, particularly imaging data, is at the heart of the healthcare system …
Miguel Guevara1, Davy Cam4, Jacques Badagbon4, Stéphane Roche4, Michel Bottlaender3, Yann Cointepas1,2, Jean-François Mangin1,2, Ludovic de Rochefort4 and Alexandre Vignaud1,2 1 CNRS BAOBAB UMR9027 Gif-Sur-Yvette, France ; 2 CEA NeuroSpin, Gif-Sur-Yvette; 3 UNIACT, NeuroSpin, CEA, Gif-sur-Yvette, France ; 4 VENTIO, Marseille, France …
Dr. Stephane ROCHE, PhD, Dr. Ludovic de ROCHEFORT, PhD; November 2022 Definition: QSM (Quantitative Susceptibility Mapping) ist ein fortschrittliches biomedizinisches Bildgebungsverfahren für die Forschung, basierend auf Magnetischer Resonanz Tommographie (MRT)1,2. Die QSM-Technologie erlaubt es die Intensität und Position magnetischcher Quellen …
QSM4SENIOR: Quantitative susceptibility mapping in the aging of the healthy brain. Miguel Guevara1,2, Davy Cam3, Jacques Badagbon3, Michel Bottlaender2, Yann Cointepas1,2, Jean-François Mangin1,2, Ludovic de Rochefort3 and Alexandre Vignaud1,2 Joint Workshop on MR phase, magnetic susceptibility and electrical properties mapping, …
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai, Kenichi Oishi and Noriyuki Matsukawa Frontiers In Neuroscience, 5 august 2022 Alzheimer’s disease (AD) is the most common type of …
Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging Chaoyue Wang, Aurea B. Martins-Bach, Fidel Alfaro-Almagro, Gwenaëlle Douaud, Johannes C. Klein, Alberto Llera, Cristiana Fiscone, Richard Bowtell, Lloyd T. Elliott, Stephen M. Smith, Benjamin C. Tendler …
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? Farzaneh Nikparast, Zohreh Ganji, Mohammad Danesh Doust, Reyhane Faraji & Hoda Zare Insights into Imaging volume 13, Article number: 74 (2022) The …
